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INTRODUCTION
Skin conditions are a major cause of 
consultations in primary care with 
approximately 2.4 million consultations per 
year in England and Wales.1 In 2010, based 
on an estimated UK population of 62 million, 
there were at least 280 000 primary care 
consultations for an abscess or boil.2
The epidemiology of boils and abscesses 
in primary care is poorly understood. 
Suppurative skin infections such as sycosis 
barbae,3 impetigo,4 and furunculosis5 
are more common in patients who are 
colonised with Staphylococcus aureus and 
there is evidence that boils and abscesses 
are associated with social deprivation, 
overcrowding, the use of communal 
facilities, obesity, diabetes, and impaired 
immunity.6–9 Patients consulting primary 
care with a boil or abscess will be treated 
either with antibiotics or with surgical 
incision and drainage,10 but treatment 
options for those with recurrent boils is 
limited beyond addressing any underlying 
immune disorders and screening for 
diabetes.11 Patients can be tested for 
staphylococcal carriage and decolonised; 
in the UK this may include screening for 
the Panton-Valentine leukocidin toxin 
(PVL).12,13 However, the effectiveness of such 
interventions is questionable and they are 
resource intensive.14,15
There is a clear need for guidance on 
how to manage patients with recurrent 
disease in the community. The aim of this 
study was to determine the burden of 
recurrent disease and identify opportunities 
for secondary prevention in these patients.
MeThOD
The THIN database is a source of 
anonymised clinical information about 
11 million patients in primary care.16 In the 
UK, 98% of the population is registered 
with a GP who provides advice, treatment, 
prescriptions, and referrals and acts 
as a gatekeeper to specialist services.17 
Practices that participate in the THIN 
scheme of data collection enter information 
on symptoms, diagnoses, treatments, 
laboratory investigations, and referrals 
every time a consultation takes place, using 
a hierarchical system of more than 103 000 
Read Codes.18 Prescriptions are recorded 
using MULTILEx drug codes that link each 
formulation of each drug to the British 
National Formulary. Each patient in the 
database is allocated a Townsend score 
linked to their postcode (which is a composite 
measure of social deprivation based on 
levels of house ownership, overcrowding, 
car ownership, and unemployment). The 
practices are broadly representative of UK 
practices in terms of the age and sex of 
patients, the practice size and geographical 
location.19 Adequacy of death recording is 
assessed by determining the date at which 
the practice recorded mortality rates that 
were comparable to national age and sex 
standardised mortality rates (AMR date).20 
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Abstract
Background 
Boils and abscesses are common in primary 
care but the burden of recurrent infection is 
unknown.
Aim
To investigate the incidence of and risk factors 
for recurrence of boil or abscess for individuals 
consulting primary care. 
Design and setting
Cohort study using electronic health records 
from primary care in the UK.
Method
The Health Improvement Network (THIN) 
database was used to identify patients who 
had consulted their GP for a boil or abscess. 
Poisson regression was used to examine the 
relationship between age, sex, social deprivation, 
and consultation and to calculate the incidence 
of, and risk factors for, repeat consultation for a 
boil or abscess. 
Results
Overall, 164 461 individuals were identified 
who consulted their GP for a boil or abscess 
between 1995 and 2010. The incidence of first 
consultation for a boil or abscess was 512 
(95% CI = 509 to 515) per 100 000 person-
years in females and 387 (95% CI = 385 to 
390) per 100 000 person-years in males. First 
consultations were most frequent in younger 
age groups (16–34 years) and those with the 
greatest levels of social deprivation. The rate of 
repeat consultation for a new infection during 
follow up was 107.5 (95% confidence interval 
[CI] = 105.6 to 109.4) per 1000 person-years. 
Obesity (relative risk [RR] 1.3, 95% CI = 1.2 
to 1.3), diabetes (RR 1.3, 95% CI = 1.2 to 1.3), 
smoking (RR 1.3, 95% CI = 1.2 to 1.4), age 
<30 years (RR 1.2, 95% CI = 1.2 to 1.3), and prior 
antibiotic use (RR 1.4, 95% CI = 1.3–1.4) were all 
associated with repeat consultation for a boil or 
abscess. 
Conclusion
Ten percent of patients with a boil or abscess 
develop a repeat boil or abscess within 
12 months. Obesity, diabetes, young age, 
smoking, and prescription of an antibiotic 
in the 6 months before initial presentation 
were independently associated with recurrent 
infection, and may represent options for 
prevention.
Keywords
abscess; boils; epidemiology; primary care; risk 
factors.
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Patients were eligible for inclusion in 
the study if they were registered with a 
participating practice that met acceptable 
mortality recording (AMR) standards and 
was fully computerised between 1 January 
1995 and 31 December 2011.21 Individuals 
were identified if they sought care for a 
boil, abscess, carbuncle, or furuncle, 
identified by a Read Code list (Appendix 1). 
Patients were excluded from the cohort if 
they were registered with a participating 
practice for <6 months before the date 
of first consultation (with the exception 
of infants aged <1 year), or if they had 
<1 year of follow-up data from that date. 
For the multivariate analysis patients with 
a diagnosis of hidradenitis suppurativa (a 
condition characterised by repeat boils) 
were excluded as these individuals were 
thought to represent a distinct patient group. 
Patients entered the cohort on the date of 
their first consultation for a boil or abscess 
and exited on the first of the following dates: 
the date of second (repeat) consultation for 
a boil or abscess; the date of death; the date 
the patient left the practice; or 31 December 
2011.
Outcome was defined as any consultation 
that resulted in a record of a boil or abscess 
occurring between 3 weeks and 12 months 
after the date of first consultation for an 
abscess or boil. Recurrent boil or abscess 
was defined as a second consultation for a 
boil or abscess that occurred a minimum of 
21 days after the previous consultation.
Exposure variables were grouped into 
past medical history, prescription history 
including antibiotics, treatment at baseline, 
and health indicators. Patients with a 
history of skin disease were identified if 
they had a record that included any of the 
following terms: ‘eczema’, ‘eczematous’, 
‘atopic eczema’, ‘psoriasis’, ‘psoriatic’, 
and ‘dermatitis’, using the methods 
described by Davé et al.22 Finally, individuals 
diagnosed with hidradenitis suppurativa 
were identified. To identify patients with 
type 1 or type 2 diabetes a combination of 
the medical, prescription, and additional 
health data records was used. Patients 
with any record corresponding to diabetes 
were classified as diabetic, even if diagnosis 
was after the date of first consultation for 
a boil or abscess, on the assumption that 
these patients were diabetic at the time of 
infection.
Therapy records were used to identify 
patients prescribed oral corticosteroids or 
antibiotics in the 6 months prior to the date 
of index consultation. The British National 
Formulary was used for classification. 
Antibiotic prescriptions in the 30 days 
before first consultation for a boil or abscess 
were disregarded in case they represented 
treatment without a corresponding medical 
record for a boil or abscess.
Antibiotic treatment at baseline was 
defined as prescription of any antibiotic 
within 2 weeks of the date of the first 
consultation for a boil or abscess.
To define smoking status the record 
closest to the date of consultation for a boil 
or abscess was used in the context of the 
patients’ longitudinal record. Body mass 
index was defined using the record in the 
additional health data file that was closest 
to the date of consultation for a boil or 
abscess.
First, Poisson regression was used to 
investigate the relationship between initial 
consultations for a boil or abscess, age, 
sex, and social deprivation. Subsequently, a 
cohort was selected from the full dataset to 
study factors associated with recurrent boil 
or abscess. The baseline characteristics 
of this cohort were summarised using 
descriptive statistics. For variables where 
>5% of patients lacked a record (for body 
mass index [BMI] and smoking status), 
patients with missing data were compared 
to those with a complete case record. 
Provided those with a missing record were 
not systematically different from those with 
a complete record, missing records were 
reclassified as within the normal range 
on the assumption that this was why they 
lacked a record, for example smoking 
status is rarely recorded in non-smokers. 
Poisson regression was used to calculate 
the incidence of repeat consultation for a boil 
or abscess taking the denominator as the 
total number of person-years contributed by 
patients in the sample population. Univariate 
analyses were performed to identify factors 
associated with repeat consultation for a boil 
or abscess. The multivariable analysis was 
how this fits in
Boils and abscesses are a common 
condition in primary care but there is 
little information on the burden of and 
risk factors for recurrent disease. In this 
study 10% of patients consulting for a 
boil or abscess developed a second boil 
or abscess during the following year. 
Consultations for boils and abscesses 
are most common in young, socially- 
deprived females and are associated with 
smoking, diabetes, obesity, and recent 
antibiotic use in the prior 6 months. Weight 
loss, smoking cessation, and reducing 
unnecessary antibiotic use could represent 
strategies for secondary prevention.
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restricted to adults aged >16 years with a 
first consultation after 1995 because factors 
such as BMI were more likely to be recorded 
in adults and data were sparse before 1995. 
Multivariable Poisson regression was used 
to identify factors associated with recurrent 
boil accounting for age and sex. Variables 
identified from the univariate analysis and 
from knowledge of the literature were 
sequentially added to the model, assessing 
for interaction with age. Antibiotic treatment 
at diagnosis was added as a binary variable 
to the final model. However, antibiotic 
treatment was not considered as a potential 
risk factor, but rather as a marker of 
disease severity, because individuals with 
a severe infection are more likely to be 
treated with an antibiotic. Lastly, the final 
model was compared with and without a 
random effects term to assess whether 
there was evidence of clustering and to 
adjust precision estimates accordingly.
ReSULTS
Between 1 January 1995 and 31 December 
2010, 164 461 people had at least one 
consultation for a boil or abscess. The 
overall incidence of consultation for a boil or 
abscess was higher in females compared 
to males at 512 (95% confidence interval 
[CI] = 509 to 515) versus 387 (95% CI = 385 to 
390) per 100 000 person-years respectively. 
However this relationship was age-
dependent and males aged ≥65 years had 
higher rates of consultation compared to 
females (Figure 1). The rate of consultation 
increased rapidly from adolescence, 
peaking in male 20–24-year-olds and 
female 30–34-year-olds, and declining 
thereafter (Figure 1). Consultations were 
most frequent in individuals with the 
highest levels of social deprivation and this 
relationship was more marked for females 
than males (Figure 2).
In total, 122 473 had a consultation for 
a boil or abscess at least 6 months after 
they registered and with at least 1 year 
of follow-up. The mean age at infection 
was comparable for both males and 
females at 41 years (Table 1). Twelve per 
cent (14 388/122 473) of the cohort had a 
recorded diagnosis of diabetes and less 
than one-fifth (22 804/122 473) had a record 
of an underlying skin condition such as 
psoriasis, eczema, or dermatitis. Diagnosis 
of hidradenitis suppurativa was rare, 
recorded in <1% (429/51 986) of males and 
2.5% (1751/70 487) of females consulting 
for a boil or abscess. Twenty-eight per 
cent (34 316/122 473) had been prescribed 
at least one antibiotic in the 6 months 
before they were diagnosed with their first 
abscess or boil and approximately one-third 
were current smokers (35 754/122 473). 
At diagnosis 71% (86 427/122 473) of 
patients consulting for a boil or abscess 
were prescribed an antibiotic and 6% 
(7609/122 473) had a record of surgical 
incision and drainage (Table 2). Flucloxacillin 
was the most commonly-prescribed 
antimicrobial, prescribed in over half of 
all cases (66 879/122 473). Mupirocin and 
chlorhexidine were rarely prescribed to 
eradicate S. aureus carriage (<2%).
Nine per cent (4762/51 986) of males and 
11% (7550/70 487) of females had at least 
one repeat consultation for a boil or abscess 
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Figure 2. Relationship between social deprivation and 
consultation for a boil or abscess by sex.
Figure 1. The relationship between age and 
consultation rate for a boil or abscess in male and 
female patients.
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Townsend quintile of deprivation
in the 3 weeks to 12 months following their 
first consultation and 3% (3622/122 473) had 
two or more repeat consultations, separated 
by at least 3 weeks. The overall rate of 
repeat consultation for a boil or abscess 
during follow-up was 107.5 (95% CI = 105.6 
to 109.4) per 1000 person-years.
In the multivariable analysis there 
was no evidence of a clinically-relevant 
interaction between age and sex (Table 3). 
Obesity (relative risk [RR] 1.3, 95% CI = 1.2 
to 1.3), diabetes (RR 1.3, 95% CI = 1.2 to 
1.3), smoking (RR 1.3, 95% CI = 1.2 to 1.4) 
and an antibiotic prescription in the prior 
6 months (RR 1.4, 95% CI = 1.3 to 1.4) were 
all independently associated with a repeat 
consultation for an abscess or boil. The 
rate of repeat consultation was highest in 
individuals aged 16–34 years and declined 
with increasing age. Antibiotic treatment 
and surgical treatment were not assessed 
as independent risk factors for recurrence 
because of the risk of confounding by 
disease severity (those at greatest risk of 
recurrent severe disease are more likely 
to be treated). Furthermore, the estimated 
rate ratios were not affected by inclusion of 
antibiotic treatment in the model as a binary 
variable, as a marker of disease severity. 
Inclusion of social deprivation (Townsend 
score) or year of first consultation did not 
impact on the estimated rate ratios.
DISCUSSION
Summary
In this large study of patients attending 
primary care, 10% reconsulted for a boil 
or abscess at least once within 1 year of 
diagnosis. Infections were more common in 
female patients but followed a marked age-
distribution in both sexes, with the greatest 
burden of disease in socially-deprived young 
adults. Factors independently associated 
with repeat consultation for boil or abscess 
were obesity, diabetes, chronic skin disease, 
current smoking, and antibiotic use in the 
6 months prior to the initial consultation.
Strengths and limitations
This study’s strengths lie in its scale and 
the fact that the dataset is broadly nationally 
representative, containing the medical 
records of approximately 6% of the UK 
population.17 The limitations relate to the 
fact that data were recorded for patient 
management and not research. Read Codes 
were used to identify patients consulting for 
a boil or abscess. However, some GPs may 
prescribe an antibiotic without recording a 
diagnostic code, thereby underestimating 
incidence. 
The actual incidence of recurrent disease 
in the community may have been higher 
because patients with a boil or abscess could 
attend an urgent care centre or go directly 
to accident and emergency for treatment. 
First recurrence was measured only and 
some patients will have multiple episodes 
of recurrent boil. By using an arbitrary 
cut-off value of 3 weeks to distinguish 
between people with a second (recurrent) 
infection and those with a prolonged first 
infection, some patients may have been 
misclassified, potentially biasing estimates 
of the recurrence rate.
Comparison with existing literature
Boils and abscesses are generally thought to 
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Table 1. Baseline characteristics of cohort
Characteristic Males, N = 51 986 Females, N = 70 487
Mean age, years, (SD) 41 (20.1) 41 (19.0)
Follow-up time, person-years 302 257 416 556
Townsend score, n (%)a  
1 (least deprived) 
2 
3 
4 
5 (most deprived) 
Not recorded
 
12 582 (24.5) 
10 554 (20.6) 
10 482 (20.4) 
10 024 (19.5) 
7714 (15.0) 
630 (1.2)
 
15 991 (23.0) 
13 768 (19.8) 
14 465 (20.8) 
14 167 (20.4) 
11 195 (16.1) 
901 (1.3)
Body mass index, n (%)b  
Mean (SD) 
Not recorded 
 
27.3 (5.3) 
7979/46 438 (17.2)
 
28.0 (6.7) 
4977/64 245 (7.8)
Diabetes, Yes, n (%) 6260 (12.0) 8128 (11.5)
Skin condition, Yes, n (%) 8568 (16.5) 14236 (20.2)
Hidradenitis suppurativa, n (%) 429 (0.83) 1751 (2.5)
Steroid prescription, n (%) 1231 (2.4) 2221 (3.2)
Antibiotics in prior 6 months, n (%) 
1 course 
>1 course
 
9806 (18.9) 
2670 (5.2)
 
16 820 (23.9) 
5020 (7.1)
Smoking status, n (%)b  
Non-smoker 
Current smoker 
Ex-smoker 
Not recorded
 
9841 (22.9) 
15 225 (35.4) 
17 934 (41.7) 
3438 (7.4)
 
16 259 (26.3) 
20 529 (33.2) 
25 035 (40.5) 
2422 (3.8)
aIn the full THIN dataset 27% of the population are in Q1, 22% Q2, 21% Q3, 18% Q4, 12% Q5. bBMI and smoking status 
only included for adults aged ≥16 years. BMI = body mass index. Q = quintile.  SD = standard deviation.
Table 2. Treatment of patients with first presentation for a boil or 
abscess
Treatment of first abscess or boil Males, N = 51 986, n (%) Females, N = 70 487, n (%)
Surgical incision and drainage 3976 (7.7) 3633 (5.2)
Proportion treated with antibiotic 36 394 (70.0) 50 033 (71.0)
Flucloxacillin 29 085 (56.0) 37 794 (53.6)
Macrolide 4900 (9.4) 8235 (11.7)
Fusidic acid 2989 (5.8) 4869 (6.9)
Tetracycline 1011 (1.9) 1274 (1.8)
Mupirocin 817 (1.6) 1246 (1.8)
Chlorhexidine 759 (1.5) 1003 (1.4)
be more common in males, although there 
is little published data to support this.10 This 
study found that females aged <65 years 
were much more likely to consult for a boil 
or abscess than males, with a reversal of 
this trend in older age groups. This may be 
partly explained by the increased tendency 
of female patients to consult their GP,23 
but it is striking that the increased rate of 
consultation starts in puberty and declines 
with increasing age and decreasing fertility. 
This suggest hormonal changes may be 
important, not only in adolescence but 
throughout a female’s reproductive years.7 
Alternatively behavioural factors such as 
hair removal through waxing or shaving of 
non-facial sites could underlie the increased 
rate of consultation in females. In both sexes 
increased social deprivation was associated 
with an increased rate of consultation, 
and this may indicate that predisposing 
behaviours and other risk factors such as 
obesity are socially stratified.
This study found that a substantial 
proportion of patients re-consult their GP 
for a further episode of boil or abscess 
within 1 year of first diagnosis. This is 
unlikely to represent ongoing treatment of 
a single infection because consultations 
were separated by a minimum of 3 weeks. 
In the UK, the mainstay of treatment for 
patients with recurrent boils or abscesses 
if they are colonised with S. aureus is 
decolonisation therapy, based on guidance 
from the National Institute for Health and 
Care Excellence (NICE).10 This treatment to 
eradicate S. aureus carriage has been used 
effectively in settings such as surgical wards 
to reduce the risk of postoperative infection.24 
More recently, community studies from the 
US have shown decolonisation may reduce 
the risk of recurrent boils and abscesses, 
particularly when an entire household is 
treated simultaneously.14,15 However there 
is little consensus on how decolonisation 
should be undertaken in the community or 
how to manage patients with recurrent boils 
who remain persistently colonised despite 
treatment.
The rate of recurrent infection was strongly 
associated with an antibiotic prescription 
in the 6 months before the patient’s first 
consultation for a boil or abscess, which 
may reflect that individuals who are 
immunosuppressed are more likely to be 
prescribed an antibiotic. Alternatively, prior 
antibiotic treatment may actually increase 
an individuals’ subsequent risk of infection. 
Previous research has linked recent antibiotic 
use to community-MRSA (Methicillin-
resistant Staphylococcus aureus),25 and it 
is plausible that antibiotics may encourage 
carriage of drug-resistant or virulent strains 
because antibiotics place selective pressure 
on antibiotic-susceptible bacteria. A further 
explanation is that individuals with prior 
antibiotic treatment have a lower threshold 
for consultation in general, and are therefore 
more likely to reconsult for a further infection, 
potentially introducing a spurious association 
between antibiotic treatment and the rate of 
repeat consultation. However, the fact that 
this analysis is restricted to those who had 
consulted at least once for a boil or abscess 
decreases the likelihood of this being a major 
effect.
Implications for research and practice
Boils and abscesses are a common 
problem and the management of recurrent 
disease is difficult. There is a clear need for 
treatment guidance in this area. Modifiable 
risk factors such as obesity, smoking, 
and antibiotic overuse are common in the 
general population and may represent 
targets for the secondary prevention of boils 
and abscesses in primary care.
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Table 3. Poisson regression model of the relationship between 
clinical and demographic risk factors and consultation for recurrent 
boil or abscess, 1995–2011
Factors associated with  
recurrent diagnosis
Crude rate per 1000 
person-years (95% CI)
Unadjusted analysis 
IRR (95% CI)
Adjusted analysisa  
IRR (95% CI)
Mean age, years (SD) 41 (20.1) 41 (19.0)
Follow-up time, person-years 30 2257 416 556
Age, years  
16–24 
25–34 
35–44 
45–54 
55–64 
65–74 
75–89
 
122.2 (116.4 to 128.3) 
127.6 (122.8 to 132.6) 
121.6 (117.2 to 126.2) 
106.9 (102.2 to 111.9) 
 89.2 (84.2 to 94.4) 
78.0 (72.4 to 84.0) 
65.9 (59.7 to 72.8)
 
1 
1.0 (1.0 to 1.1) 
1.0 (0.9 to 1.1) 
0.9 (0.8 to 0.9) 
0.7 (0.7 to 0.8) 
0.6 (0.6 to 0.7) 
0.5 (0.5 to 0.6)
 
1 
1.0 (0.9 to 1.1) 
0.9 (0.9 to 1.0) 
0.8 (0.8 to 0.9) 
0.7 (0.7 to 0.8) 
0.6 (0.6 to 0.7) 
0.6 (0.5 to 0.6)
Male 
Female
97.3 (94.6 to 100.1) 
115.1 (112.5 to 117.7)
1 
1.2 (1.1 to 1.2)
1 
1.1 (1.0 to 1.1)
BMI, kg/m2  
<30 
≥30
 
100.9 (98.6 to 103.2) 
133.2 (128.8 to 137.6)
 
1 
1.3 (1.3 to 1.4)
 
1 
1.3 (1.2 to 1.3)
Diabetes 
No 
Yes
 
104.7 (102.7 to 106.7) 
128.9 (122.9 to 135.2)
 
1 
1.2 (1.2 to 1.3)
 
1 
1.3 (1.2 to 1.3)
Skin disease 
No 
Yes
 
105.4 (103.3 to 107.5) 
116.7 (112.2 to 121.5)
 
1 
1.1 (1.1 to 1.2)
 
1 
1.1 (1.0 to 1.1)
No prior antibiotics 
1 course 
>1 course 
95.2 (93.1 to 97.4) 
133.7 (129.1 to 138.4) 
162.0 (152.7 to 171.8)
1 
1.4 (1.4 to 1.5) 
1.7 (1.6 to 1.8)
1 
1.4 (1.3 to 1.4) 
1.6 (1.5 to 1.7)
Smoker 
No 
Yes
 
97.1 (94.8 to 99.5) 
135.0 (131.1 to 139.1)
 
1 
1.4 (1.2 to 1.4)
 
1 
1.3 (1.2 to 1.4)
P-value (LRTa) <0.0001
aLRT comparing simple model (age, sex and bmi) to final model. BMI = body mass index. IRR = incidence rate ratio. 
LRT =  Likelihood ratio test
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Appendix 1. Read Code lists for boils and abscesses
Read Code lists were developed to identify a patient with an abscess or boil using a three-stage process. First a 
word-search was performed on the Read Code dictionary using the terms ‘abscess’, ‘boil’, ‘furuncle’, ‘carbuncle’ 
and ‘staphylococcal skin’. Next Read Codes identified in the word-search were included as search terms to identify 
additional codes. Finally, unwanted codes were manually excluded and reviewed and the code list was finalised 
with all research collaborators including a GP familiar with Vision. Codes were excluded where the diagnosis of 
boil or abscess was mixed with a diagnosis of cellulitis, as were codes for parionychias and perionychias because 
patients with these conditions tended to be older and did not reflect the target population of young and healthy 
individuals with community-onset disease. Read Code lists for boils and abscesses are included.
Read Code Description
7303100 Drainage of abscess of external ear
7G25011 Drainage of abscess of head or neck
7G25012 Drainage of boil of skin of head or neck
7G25111 Drainage of abscess NEC
7G25112 Drainage of boil of skin NEC
7G25211 Incision of boil of skin of head or neck
7G25311 Incision of boil of skin NEC
7G25700 Incision and drainage of abscess
F4G0200 Orbital abscess
F501111 Abscess external ear
F506.00 Abscess of external ear
H1y1000 Nasal septum abscess
H1y1011 Boil in nose
K310.11 Abscess breast non puerperal
K310400 Acute nonpuerperal breast abscess
K310500 Chronic nonpuerperal breast abscess
K310600 Chronic subareolar nonpuerperal abscess
K318.00 Breast abscess
L450.11 Abscess of nipple — obstetric
L451.00 Obstetric breast abscess
L451000 Obstetric breast abscess unspecified
L451100 Obstetric breast abscess — delivered
L451200 Obstetric breast abscess — delivery with postnatal complication
L451300 Obstetric breast abscess with antenatal complication
L451400 Obstetric breast abscess with postnatal complication
L451z00 Obstetric breast abscess NOS (not otherwise specified)
M00..00 Carbuncle
M000.00 Carbuncle of face
M000000 Carbuncle of ear
M000100 Carbuncle of face (excluding eye)
M000200 Carbuncle of nasal septum
M000300 Carbuncle of temple region
M000z00 Carbuncle of face NOS
M001.00 Carbuncle of neck
M002.00 Carbuncle of trunk
M002000 Carbuncle of chest wall
M002100 Carbuncle of breast
M002200 Carbuncle of back
M002400 Carbuncle of umbilicus
M002500 Carbuncle of flank
M002600 Carbuncle of groin
M002700 Carbuncle of perineum
M002z00 Carbuncle of trunk NOS
M003.00 Carbuncle of upper arm and forearm
M003000 Carbuncle of shoulder
M003100 Carbuncle of axilla
M003200 Carbuncle of upper arm
M003300 Carbuncle of elbow
M003400 Carbuncle of forearm
M003z00 Carbuncle of upper arm and forearm NOS
M004.00 Carbuncle of hand
M004000 Carbuncle of wrist
M004100 Carbuncle of thumb
M004200 Carbuncle of finger
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Appendix 1 continued. Read Code lists for boils and abscesses
Read Code Description
M004z00 Carbuncle of hand NOS
M005.00 Carbuncle of buttock
M005000 Carbuncle of anus
M005100 Carbuncle of gluteal region
M005z00 Carbuncle of buttock NOS
M006.00 Carbuncle of leg (excluding foot)
M006000 Carbuncle of hip
M006100 Carbuncle of thigh
M006200 Carbuncle of knee
M006300 Carbuncle of lower leg
M006400 Carbuncle of ankle
M006z00 Carbuncle of leg (excluding foot) NOS
M007.00 Carbuncle of foot
M007000 Carbuncle of foot unspecified
M007100 Carbuncle of heel
M007200 Carbuncle of toe
M007z00 Carbuncle of foot NOS
M00y.00 Carbuncle of other specified site
M00y000 Carbuncle of head (excluding face)
M00yz00 Carbuncle of other specified site NOS
M00z.00 Carbuncle NOS
M01..00 Furuncle — boil
M010.00 Boil of face
M010000 Boil of ear
M010100 Boil of face (excluding eye)
M010200 Boil of nasal septum
M010300 Boil of temple region
M010400 Boil of external nose
M010z00 Boil of face NOS
M011.00 Boil of neck
M012.00 Boil of trunk
M012000 Boil of chest wall
M012100 Boil of breast
M012200 Boil of back
M012300 Boil of abdominal wall
M012400 Boil of umbilicus
M012500 Boil of flank
M012600 Boil of groin
M012z00 Boil of trunk NOS
M013.00 Boil of upper arm and forearm
M013000 Boil of shoulder
M013100 Boil of axilla
M013200 Boil of upper arm
M013300 Boil of elbow
M013400 Boil of forearm
M013z00 Boil of upper arm and forearm NOS
M014.00 Boil of hand
M014000 Boil of wrist
M014100 Boil of thumb
M014200 Boil of finger
M014z00 Boil of hand NOS
M015.00 Boil of buttock
M015000 Boil of anus
M015100 Boil of gluteal region
M015z00 Boil of buttock NOS
M016.00 Boil of leg (excluding foot)
M016000 Boil of hip
M016100 Boil of thigh
M016200 Boil of knee
M016300 Boil of lower leg
M016400 Boil of ankle
M016z00 Boil of leg (excluding foot) NOS
M017.00 Boil of foot
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Read Code Description
M017000 Boil of foot unspecified
M017100 Boil of heel
M017200 Boil of toe
M017z00 Boil of foot NOS
M01y.00 Boil of other specified site
M01y000 Boil of head (excluding face)
M01yz00 Boil of other specified site NOS
M01z.00 Boil NOS
M01z.11 Recurrent boils
M01z.12 Boils of multiple sites
M01z000 Multiple boils
M020100 Finger pulp abscess
M03..11 Abscess of skin area excluding digits of hand or foot
M034011 Abscess of dorsum of hand
M034012 Abscess of palm of hand
M03y011 Abscess of scalp
M03z100 Abscess NOS
M09..00 Cutaneous abscess
M090.00 [x]Abscess of face
M091.00 [x]Abscess of neck
M092.00 [x]Abscess of trunk
M092000 [x]Abscess of buttock
M093.00 [x]Abscess of buttock
M094.00 [x]Abscess of limb
M094000 [x]Abscess of axilla
M095.00 Skin abscess
